Clorox Q4 Earnings Beat Estimates, Organic Sales Increase Y/Y

Clorox (CLX) reported strong Q4 fiscal 2025 results, with net sales of $1.99 billion (+4.5% YoY) and adjusted EPS of $2.87 (+57.7% YoY), both surpassing consensus estimates, largely propelled by incremental ERP-related shipments. However, the company provided a cautious fiscal 2026 outlook, projecting net sales to decline 6-10% and adjusted EPS to fall 18-23%, primarily due to the reversal of these temporary ERP shipment benefits and ongoing digital transformation investments. This guidance signals a significant near-term earnings headwind as the company cycles the ERP-driven gains while absorbing strategic investment costs.

Analysis

The Clorox Company (CLX) reported fourth-quarter fiscal 2025 results that, on the surface, appeared strong but were fundamentally distorted by a one-time benefit from its enterprise resource planning (ERP) system transition. While net sales grew 4.5% to $1.99 billion and adjusted EPS surged 57.7% to $2.87, both beating estimates, these figures were artificially inflated. The ERP rollout prompted incremental shipments that boosted volume by 13-14 percentage points and added 85 to 95 cents to EPS, masking what would have otherwise been a weak quarter. Gross margin remained flat at 46.5% only due to a 150 basis point contribution from these shipments, which offset headwinds from rising manufacturing costs and trade promotions. The critical takeaway, however, lies in the fiscal 2026 guidance, which projects a sharp reversal of this temporary gain. The company anticipates a 6-10% decline in net sales and a significant 18-23% drop in adjusted EPS, primarily driven by the normalization of shipment volumes. This outlook, combined with ongoing operating costs from a multi-year, $570-$580 million digital transformation initiative, signals a challenging year ahead and explains the stock's recent 9.7% decline, which has underperformed its industry.

Key Decisions for Investors

• Investors should look past the headline Q4 fiscal 2025 earnings beat, as it was driven by a temporary, non-recurring shipment pull-forward related to an ERP system transition.
• Expect significant near-term pressure on the stock, as fiscal 2026 guidance points to a sharp 18-23% decline in adjusted EPS and a 6-10% drop in net sales due to the reversal of the ERP benefits.
• It is critical to monitor underlying consumer demand and competitive pressures, which the article notes were soft, as these fundamentals were masked by the ERP-related volume boost.
• Given the weak forward guidance and recent share price underperformance, consider re-evaluating long positions and weigh the company's long-term transformation goals against the pronounced short-term earnings and margin headwinds.